Recent studies targeted the NALP1 inflammasome [40], IL-6 [41], and chemotactic protein [42] in efforts to significantly reduce inflammation in brain injury, myocardiac infarction, and pulmonary emphysema, respectively. The gene discussed is NLRP1; the disease is pulmonary emphysema.